LXEO Lexeo Therapeutics Inc.

Price (delayed)

$4.78

Market cap

$375.33M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.32

Enterprise value

$307.68M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 11

We are a clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. By taking aim at the underlying genetic ...

Highlights
The EPS has surged by 60% year-on-year and by 29% since the previous quarter
The quick ratio rose by 26% since the previous quarter
LXEO's equity has soared by 163% year-on-year but it is down by 6% since the previous quarter

Key stats

What are the main financial stats of LXEO

LXEO stock price

How has the Lexeo Therapeutics stock price performed over time
Intraday
6.22%
1 week
-5.91%
1 month
-17.59%
1 year
54.19%
YTD
-51.86%
QTD
-16.72%

Financial performance

How have Lexeo Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$97.79M
Net income
-$87.5M
Gross margin
N/A
Net margin
N/A
LXEO's net income is up by 20% YoY and by 12% QoQ
The operating income has increased by 16% YoY and by 11% from the previous quarter

Price vs fundamentals

How does LXEO's price correlate with its fundamentals

Growth

What is Lexeo Therapeutics's growth rate over time

Valuation

What is Lexeo Therapeutics stock price valuation
P/E
N/A
P/B
1.53
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 60% year-on-year and by 29% since the previous quarter
LXEO's equity has soared by 163% year-on-year but it is down by 6% since the previous quarter
The P/B is 35% below the last 4 quarters average of 2.2

Efficiency

How efficient is Lexeo Therapeutics business performance
Lexeo Therapeutics's ROIC has soared by 76% YoY and by 27% from the previous quarter
Lexeo Therapeutics's return on equity has increased by 45% YoY and by 29% QoQ
The ROA has grown by 39% YoY and by 26% from the previous quarter

Dividends

What is LXEO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LXEO.

Financial health

How did Lexeo Therapeutics financials performed over time
The company's total assets has surged by 99% YoY but it fell by 7% QoQ
Lexeo Therapeutics's total liabilities has decreased by 50% YoY and by 14% from the previous quarter
The debt is 97% less than the equity
LXEO's equity has soared by 163% year-on-year but it is down by 6% since the previous quarter
The debt to equity has plunged by 73% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.